sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Updated 10/6/2026, 4:41 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | Sale | $331,856 | Gault Cheryl Chief Operating Officer | 10,000 sh | at $33.19 | Filed Oct 1, 4:30 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $86,565 | Ceesay Abraham Chief Executive Officer, Director | 2,210 sh | at $39.17 | Filed Sep 24, 4:05 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $374,498 | Ceesay Abraham Chief Executive Officer, Director | 8,210 sh | at $45.61 | Filed Sep 9, 4:05 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $937,957 | Ceesay Abraham Chief Executive Officer, Director | 18,921 sh | at $49.57 | Filed Aug 26, 4:05 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $2,531,582 | Yeleswaram Krishnaswamy Chief Development Officer | 50,160 sh | at $50.47 | Filed Aug 26, 4:00 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $20,160 | Yeleswaram Krishnaswamy Chief Development Officer | 404 sh | at $49.90 | Filed Aug 20, 4:09 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $2,433,176 | Ceesay Abraham Chief Executive Officer, Director | 51,499 sh | at $47.25 | Filed Aug 12, 4:35 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $93,061 | Ceesay Abraham Chief Executive Officer, Director | 2,210 sh | at $42.11 | Filed Jul 29, 4:05 PM ET | Filing | |
| RAPP Rapport Therapeutics, Inc. | Sale | $328,437 | Ceesay Abraham Chief Executive Officer, Director | 8,210 sh | at $40.00 | Filed Jul 15, 4:15 PM ET | Filing |